Brian Lundstrom
Chief Executive Officer bei Abvivo LLC
Profil
Brian Lundstrom is the founder of Abvivo LLC, which was founded in 2019.
He is currently the Chief Business Officer at Open Monoclonal Technology, Inc. He has also held positions at Cellastra, Inc., ImmunoPrecise Antibodies Ltd., Ligand Pharmaceuticals, Inc., SangStat Medical Corp., ACADIA Pharmaceuticals, Inc., and Genzyme Corp.
Mr. Lundstrom has an MBA from Seattle University and Copenhagen Business School.
He also has a graduate degree from the Technical University of Denmark.
Aktive Positionen von Brian Lundstrom
| Unternehmen | Position | Beginn |
|---|---|---|
Open Monoclonal Technology, Inc.
 Open Monoclonal Technology, Inc. BiotechnologyHealth Technology Open Monoclonal Technology, Inc. engages in the genetic engineering of animals for discovery of human therapeutic antibodies. The firm’s transgenic animal platforms include OmniRat, industry’s first human monoclonal antibody technology based on rats; OmniMouse, a transgenic mouse that complements OmniRat and expands epitope coverage and; OmniFlic, the first engineered rat with a fixed light chain for development of bispecific, fully human antibodies. The company was founded in by Roland Buelow 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01.01.2012 |
| Abvivo LLC | Chief Executive Officer | 01.01.2019 |
Ehemalige bekannte Positionen von Brian Lundstrom
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUNOPRECISE ANTIBODIES LTD. | Director/Board Member | 30.11.2021 |
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01.06.2021 |
Cellastra, Inc.
 Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation. | Director/Board Member | 01.01.2019 |
Windy Hill Medical, Inc.
 Windy Hill Medical, Inc. Medical SpecialtiesHealth Technology Windy Hill Medical, Inc. manufactures and supplies medical devices. The firm focuses on the development of products to reduce the risk of breast cancer. The company was founded by Dr. Susan Love in 2004 and is headquartered in Laguna Hills, CA. | President | 28.05.2012 |
| INTERNATIONAL STEM CELL CORPORATION | President | 11.05.2011 |
Ausbildung von Brian Lundstrom
| Seattle University | Masters Business Admin |
| Copenhagen Business School | Masters Business Admin |
| Technical University of Denmark | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| INTERNATIONAL STEM CELL CORPORATION | Health Technology |
| IMMUNOPRECISE ANTIBODIES LTD. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
| SangStat Medical Corp. | Health Technology |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Windy Hill Medical, Inc.
Windy Hill Medical, Inc. Medical SpecialtiesHealth Technology Windy Hill Medical, Inc. manufactures and supplies medical devices. The firm focuses on the development of products to reduce the risk of breast cancer. The company was founded by Dr. Susan Love in 2004 and is headquartered in Laguna Hills, CA. | Health Technology |
Oxford GlycoSciences Plc
 Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
Open Monoclonal Technology, Inc.
Open Monoclonal Technology, Inc. BiotechnologyHealth Technology Open Monoclonal Technology, Inc. engages in the genetic engineering of animals for discovery of human therapeutic antibodies. The firm’s transgenic animal platforms include OmniRat, industry’s first human monoclonal antibody technology based on rats; OmniMouse, a transgenic mouse that complements OmniRat and expands epitope coverage and; OmniFlic, the first engineered rat with a fixed light chain for development of bispecific, fully human antibodies. The company was founded in by Roland Buelow 2007 and is headquartered in San Diego, CA. | Health Technology |
| Brexys | |
Cellastra, Inc.
Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation. | Health Technology |
| Abvivo LLC |
